His primary areas of investigation include Biochemistry, Bactericidal/permeability-increasing protein, Escherichia coli, Microbiology and Bacteria. His study brings together the fields of Molecular biology and Biochemistry. His Bactericidal/permeability-increasing protein research is multidisciplinary, incorporating perspectives in Lipopolysaccharide, Cytotoxic T cell, Membrane and Active protein.
The study incorporates disciplines such as Neutrophil elastase and Gram-negative bacteria in addition to Microbiology. His Bacteria study integrates concerns from other disciplines, such as Extracellular, Amino acid sequence analysis, Human neutrophil and Host defence. His work deals with themes such as Proinflammatory cytokine, Cell culture and TLR4, which intersect with Cell activation.
Jerrold Weiss mainly investigates Biochemistry, Microbiology, Escherichia coli, Bacteria and Bactericidal/permeability-increasing protein. His research in Phospholipase A2, Cell activation, Phospholipase, Enzyme and Receptor are components of Biochemistry. His Microbiology study combines topics from a wide range of disciplines, such as Extracellular, Lipopolysaccharide, Gram-negative bacteria and Staphylococcus aureus.
Jerrold Weiss usually deals with Escherichia coli and limits it to topics linked to Membrane protein and Membrane glycoproteins. His Bacteria research incorporates elements of Respiratory burst, Cell envelope and Virulence. His study explores the link between Bactericidal/permeability-increasing protein and topics such as Cytotoxic T cell that cross with problems in Degranulation.
Jerrold Weiss spends much of his time researching TLR4, Biochemistry, Cell biology, Lipid A and Lipopolysaccharide. His biological study spans a wide range of topics, including Extracellular, Molecular biology and Tumor necrosis factor alpha. His Biochemistry research includes themes of Biophysics and Bacteria.
The Bacteria study combines topics in areas such as Phospholipase A2 and Potency. Within one scientific family, Jerrold Weiss focuses on topics pertaining to Microbiology under Potency, and may sometimes address concerns connected to Escherichia coli. His studies in Lipopolysaccharide integrate themes in fields like Bacterial outer membrane and Vesicle.
His main research concerns TLR4, Lymphocyte antigen 96, Lipid A, Immunology and Cell biology. He has included themes like Molecular biology and Eritoran in his TLR4 study. His work in Molecular biology addresses subjects such as Tumor necrosis factor alpha, which are connected to disciplines such as Virology, CD14, Fusion protein, Toll-like receptor and Proinflammatory cytokine.
His Lymphocyte antigen 96 research is multidisciplinary, incorporating elements of Wild type, Stereochemistry and Ectodomain. His Lipid A study combines topics in areas such as Acetylation and Mutant. His work on Bone marrow, Antigen, T cell and Lipopolysaccharide as part of his general Immunology study is frequently connected to Nucleosome binding, thereby bridging the divide between different branches of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes.
J Weiss;P Elsbach;I Olsson;H Odeberg.
Journal of Biological Chemistry (1978)
High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide.
H Gazzano-Santoro;J B Parent;L Grinna;A Horwitz.
Infection and Immunity (1992)
Isolation of an endotoxin–MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations
Theresa L. Gioannini;Athmane Teghanemt;DeSheng Zhang;Nathan P. Coussens.
Proceedings of the National Academy of Sciences of the United States of America (2004)
The TLR4 antagonist Eritoran protects mice from lethal influenza infection
Kari Ann Shirey;Wendy Lai;Alison J. Scott;Michael Lipsky.
Nature (2013)
Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship.
P Elsbach;J Weiss;R C Franson;S Beckerdite-Quagliata.
Journal of Biological Chemistry (1979)
Neutrophil elastase targets virulence factors of enterobacteria.
Yvette Weinrauch;Doreen Drujan;Steven D. Shapiro;Jerrold Weiss.
Nature (2002)
NEUTROPHILS EXPOSED TO BACTERIAL LIPOPOLYSACCHARIDE UPREGULATE NADPH OXIDASE ASSEMBLY
F R DeLeo;J Renee;S McCormick;M Nakamura.
Journal of Clinical Investigation (1998)
Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
J Weiss;P Elsbach;C Shu;J Castillo.
Journal of Clinical Investigation (1992)
Role of the bactericidal/permeability-increasing protein in host defence.
Peter Elsbach;Jerrold Weiss.
Current Opinion in Immunology (1998)
Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils.
Jerrold Weiss;Jerrold Weiss;Inge Olsson;Inge Olsson.
Blood (1987)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
New York University
Boston Children's Hospital
University of Iowa
National Institute of Chemistry
University of Iowa
The University of Texas Southwestern Medical Center
University of Iowa
Utrecht University
Buck Institute for Research on Aging
University of Hawaii at Manoa
University of Murcia
Carnegie Mellon University
University College London
University of Malaya
Jožef Stefan Institute
Rutgers, The State University of New Jersey
University of Birmingham
Swedish University of Agricultural Sciences
King's College London
University of Liverpool
United States Geological Survey
Stanford University
Roche (Switzerland)
National Institutes of Health
University of Turin
KU Leuven